Prior Authorization for Molecular & Genomic Testing Procedure Codes and Descriptions
Effective date
Jan 1, 2021
Identified
Jun 20, 2026
Summary
Healthfirst uses eviCore to provide authorization services for genetic and molecular laboratory services requested for members enrolled in Medicare, Medicaid and Commercial plans, for dates of service beginning January 1, 2021. Prior authorization applies to the listed molecular and genomic testing procedure codes, which include BRCA1 and BRCA2 analysis, CYP drug metabolism tests, CFTR and other known familial variant analyses, cytogenomic microarray analysis, hereditary cancer and cardiac genomic panels, oncology gene expression profiles, and molecular pathology procedures Level 1 through Level 9, along with several HCPCS S-codes for specific genetic tests.
Get alerts when payers change rules like this one
We check Healthfirst and other payers every day and email you when a change matches your specialty and state.
01Already effective January 1, 2021: Get prior authorization through eviCore for the molecular and genomic testing procedure codes listed in the policy when they are requested for Healthfirst members enrolled in Medicare, Medicaid or Commercial plans.
02Check hfproviders.org periodically for additional information about this process.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.